Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2018-11-14
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$2.34+6,400729,792+1%+$14,984
2018-11-14
BCDABiocardia, Inc.Stertzer Simon HDirP - Purchase$2.14+1,0003,585,0940%+$2,141
2018-11-15
BOLDAudentes Therapeutics, Inc.Lange Louis GDirS - Sale$22.49-24,000411,933-6%-$539,760
D
2018-11-15
SGMOSangamo Therapeutics, IncYi KathySVP, CFOS - Sale+OE$10.00-5,0007,250-41%-$50,000
2018-11-14
SGMOSangamo Therapeutics, IncParker H StewartDirP - Purchase$9.00+2,0007,500+36%+$18,002
M
2018-11-14
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$34.62-7,800768,563-1%-$270,052
M
2018-11-13
DNLIDenali Therapeutics Inc.Watts Ryan J.Pres, CEOS - Sale$18.09-18,3342,741,809-1%-$331,664
2018-11-15
ATRAAtara Biotherapeutics, Inc.Haqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$33.81-775305,5800%-$26,203
M
2018-11-12
NKNantkwest, Inc.Gorlin SteveDirS - Sale$2.29-196,280321,720-38%-$450,068
2018-11-12
MNTAMomenta Pharmaceuticals IncBeltramello Jo AnnChief HR, Inf. OfficerS - Sale$13.15-352135,6220%-$4,629
2018-11-12
MNTAMomenta Pharmaceuticals IncFier IanChief Mfg, Program OfficerS - Sale$13.15-35280,6270%-$4,629
2018-11-12
MNTAMomenta Pharmaceuticals IncKwon YoungSVP, Chief Business OfficerS - Sale$13.15-530111,5760%-$6,970
2018-11-12
MNTAMomenta Pharmaceuticals IncManning Anthony M.Chief Scientific OfficerS - Sale$13.15-11362,8140%-$1,486
D
2018-11-09
BLUEBluebird Bio, Inc.Walsh Jeffrey T.Chief FinancialS - Sale+OE$130.59-1,50035,495-4%-$195,891
M
2018-11-12
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$2.16+3,900723,392+1%+$8,412
2018-11-13
BCDABiocardia, Inc.Stertzer Simon HDirP - Purchase$2.10+1,0003,584,0940%+$2,100
2018-11-12
NBIXNeurocrine Biosciences IncPops Richard FDirS - Sale$103.30-4,12333,636-11%-$425,893
2018-11-08
ONVOOrganovo Holdings, Inc.Presnell Sharon CollinsChief Scientific OfficerS - Sale$1.27-40,000292,193-12%-$50,800
2018-11-09
HSKAHeska CorpWilson Kevin S.CEO, PresS - Sale$104.07-3,190410,472-1%-$331,992
D
2018-11-08
MNTAMomenta Pharmaceuticals IncManning Anthony M.Chief Scientific OfficerS - Sale+OE$14.09-22962,9270%-$3,227
D
2018-11-08
MNTAMomenta Pharmaceuticals IncFier IanChief Mfg, Program OfficerS - Sale+OE$14.09-21880,9790%-$3,072
D
2018-11-08
MNTAMomenta Pharmaceuticals IncBeltramello Jo AnnChief HR, Inf. OfficerS - Sale+OE$14.09-409135,9740%-$5,763
DM
2018-11-08
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale+OE$13.50-4,374583,489-1%-$59,043
D
2018-11-08
MNTAMomenta Pharmaceuticals IncKwon YoungSVP, Corporate DevelopmentS - Sale+OE$14.09-646112,106-1%-$9,102
2018-11-07
GNMXAevi Genomic Medicine, Inc.Grano Joseph J JrDirP - Purchase$1.16+68,000174,847+64%+$78,932
D
2018-11-08
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$110.00-36,295135,997-21%-$3,992,450
D
2018-11-08
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$61.54-20,148732,613-3%-$1,239,873
M
2018-11-08
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$2.50+500719,4920%+$1,251
A
2018-06-20
TROVTrovagene, Inc.Markin Rodney SDirP - Purchase$0.85+41,20043,085>999%+$35,020
2018-11-07
RGNXRegenxbio Inc.Christmas Patrick J.SVP, GCS - Sale$72.06-15,0002,669-85%-$1,080,900
DM
2018-11-07
BCRXBiocryst Pharmaceuticals IncStaab Thomas R IISVP, CFOS - Sale+OE$8.12-14,087137,383-9%-$114,387
DM
2018-11-07
BCRXBiocryst Pharmaceuticals IncPowell LynneSVP - CCOS - Sale+OE$8.14-5,5808,605-39%-$45,432
DM
2018-11-06
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$110.13-38,819135,997-22%-$4,275,300
DM
2018-11-06
NBIXNeurocrine Biosciences IncLloyd-Smith MalcolmChief Regulatory OfficerS - Sale+OE$110.01-9,00015,318-37%-$990,096
2018-11-06
CSBRChampions Oncology, Inc.Mendelson Daniel NewmanDirS - Sale$13.75-5,00057,500-8%-$68,750
2018-11-07
ATRAAtara Biotherapeutics, Inc.Marcus Joel SDirS - Sale$36.35-10,000919,945-1%-$363,500
A
2014-10-21
ATRAAtara Biotherapeutics, Inc.Marcus Joel SDirP - Purchase$11.00+9,0909,090New+$99,990
D
2018-11-06
VCELVericel CorpColangelo DominickPres, CEOS - Sale+OE$15.39-50,00075,163-40%-$769,500
2018-11-07
ATRAAtara Biotherapeutics, Inc.Gallagher Carol GiltnerDirS - Sale$36.38-21,37488,818-19%-$777,586
D
2018-11-05
RGNXRegenxbio Inc.Yoo StephenChief Medical OfficerS - Sale+OE$68.28-20,4140-100%-$1,393,933
2018-11-05
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale$68.25-20,000306,000-6%-$1,364,902
D
2018-11-06
SGMOSangamo Therapeutics, IncConner Edward R.SVP, Chief Medical OfficerS - Sale+OE$13.73-5,00012,125-29%-$68,650
2018-11-05
BCDABiocardia, Inc.McClung DavidCFOP - Purchase$2.56+1,6006,200+35%+$4,102
D
2018-11-05
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale+OE$137.38-1,80030,871-6%-$247,277
D
2018-11-05
BCRXBiocryst Pharmaceuticals IncPowell LynneSVP - CCOS - Sale+OE$8.00-1008,605-1%-$800
D
2018-11-05
BCRXBiocryst Pharmaceuticals IncStaab Thomas R IISVP, CFOS - Sale+OE$8.00-215137,3830%-$1,720
2018-11-02
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$2.52+400718,9920%+$1,008
2018-11-02
BCDABiocardia, Inc.Stertzer Simon HDirP - Purchase$2.53+2,0003,583,0940%+$5,060
2018-11-05
RGENRepligen CorpRyan Thomas F JrDirS - Sale$65.75-1,7633,225-35%-$115,920
D
2018-11-02
TWSTTwist Bioscience CorpCrandell KeithDir, 10%P - Purchase$14.00+75,000954,146+9%+$1,050,000
D
2018-11-02
TWSTTwist Bioscience CorpArch Venture Partners Viii, LLC10%P - Purchase$14.00+75,000954,146+9%+$1,050,000
D
2018-11-02
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale+OE$133.64-5,00024,905-17%-$668,216
D
2018-11-02
BCRXBiocryst Pharmaceuticals IncPowell LynneSVP - CCOS - Sale+OE$8.00-1,0008,605-10%-$8,000
D
2018-11-02
BCRXBiocryst Pharmaceuticals IncStaab Thomas R IISVP, CFOS - Sale+OE$7.84-10,856137,383-7%-$85,090
2018-11-05
HEBHemispherx Biopharma IncAppelrouth StewartDirP - Purchase$0.22+25,238266,988+10%+$5,552
D
2018-11-01
GILDGilead Sciences IncMartin John CDirS - Sale+OE$69.55-50,0003,017,762-2%-$3,477,617
2018-11-01
EDITEditas Medicine, Inc.Bosley KatrinePres, CEOS - Sale$26.88-12,0001,228,966-1%-$322,508
DM
2018-11-01
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale+OE$70.20-73,418137,283-35%-$5,154,020
2018-11-02
NBIXNeurocrine Biosciences IncLyons Gary ADirS - Sale$114.41-15,000245,697-6%-$1,716,213
2018-11-01
BCRXBiocryst Pharmaceuticals IncPowell LynneSVP - CCOS - Sale$7.51-1,5448,605-15%-$11,595
D
2018-11-01
ATRAAtara Biotherapeutics, Inc.Newell JoeChief Tech. Operations OfficerS - Sale+OE$35.00-1,50031,858-4%-$52,500
D
2018-11-01
AERIAerie Pharmaceuticals IncKopczynski Casey C.Chief Scientific OfficerS - Sale+OE$53.87-11,000128,743-8%-$592,521
2018-10-30
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$2.55+300718,5920%+$765
D
2018-10-29
RGNXRegenxbio Inc.Yoo StephenChief Medical OfficerS - Sale+OE$62.37-20,4140-100%-$1,273,212
2018-10-29
NBIXNeurocrine Biosciences IncPops Richard FDirS - Sale$107.13-5,50037,759-13%-$589,237
D
2018-10-26
EDITEditas Medicine, Inc.Hack Andrew A. F.CFOS - Sale+OE$25.70-6,0000-100%-$154,200
M
2018-10-25
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$2.36+3,850718,292+1%+$9,080
2018-10-26
HEBHemispherx Biopharma IncEquels Thomas K.Exec. Vice COB, CEO, PresP - Purchase$0.20+3,500775,8070%+$711
D
2018-10-23
LOGCLogicbio Therapeutics, Inc.Arix Bioscience Plc10%P - Purchase$10.00+700,0002,979,023+31%+$7,000,000
D
2018-10-23
LOGCLogicbio Therapeutics, Inc.Orbimed Advisors LLCDir, 10%P - Purchase$10.00+1,190,0006,466,783+23%+$11,900,000
D
2018-10-23
LOGCLogicbio Therapeutics, Inc.Kariv TomerDirP - Purchase$10.00+420,0001,787,413+31%+$4,200,000
D
2018-10-23
LOGCLogicbio Therapeutics, Inc.Ioannidou SofiaDirP - Purchase$10.00+420,0001,787,413+31%+$4,200,000
D
2018-10-23
LOGCLogicbio Therapeutics, Inc.O'Connell Daniel PDirP - Purchase$10.00+700,0002,979,023+31%+$7,000,000
D
2018-10-23
LOGCLogicbio Therapeutics, Inc.Chimovits ErezDirP - Purchase$10.00+490,0003,487,760+16%+$4,900,000
2018-10-25
HEBHemispherx Biopharma IncEquels Thomas K.Exec. Vice COB, CEO, PresP - Purchase$0.20+100,000772,307+15%+$20,000
M
2018-10-22
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$33.95-7,800776,363-1%-$264,796
D
2018-10-19
BCRXBiocryst Pharmaceuticals IncStaab Thomas R IISVP, CFOS - Sale+OE$7.45-3,150137,383-2%-$23,468
2018-10-19
BCRXBiocryst Pharmaceuticals IncPowell LynneSVP - CCOS - Sale$7.50-10010,149-1%-$750
2018-10-18
KRYSKrystal Biotech, Inc.Krishnan SumaCOO, 10%P - Purchase$20.00+25,0004,150,086+1%+$500,000
2018-10-18
KRYSKrystal Biotech, Inc.Krishnan Krish SPres, CEO, 10%P - Purchase$20.00+25,0004,150,086+1%+$500,000
2018-10-19
TTNPTitan Pharmaceuticals IncRecli Federico SeghiDirP - Purchase$0.00+200,000800,845+33%+$0
2018-10-18
EIGREiger Biopharmaceuticals, Inc.Interwest Partners X LP10%S - Sale$12.06-237,2651,362,327-15%-$2,862,321
D
2018-10-18
RGNXRegenxbio Inc.Christmas Patrick J.SVP, GCS - Sale+OE$61.78-5,00017,669-22%-$308,890
DM
2018-10-17
EDITEditas Medicine, Inc.Myer VickeshCTOS - Sale+OE$29.20-7,0000-100%-$204,370
D
2018-10-16
RGNXRegenxbio Inc.Simpson CurranSVP, Technical OperationsS - Sale+OE$60.85-62,30939,500-61%-$3,791,503
D
2018-10-15
ALLOAllogene Therapeutics, Inc.Witte Owen N.DirP - Purchase$18.00+15,000236,182+7%+$270,000
D
2018-10-15
ALLOAllogene Therapeutics, Inc.Humer Franz BDirP - Purchase$18.00+30,000104,870+40%+$540,000
D
2018-10-15
ALLOAllogene Therapeutics, Inc.Chang David DPres, CEOP - Purchase$18.00+40,0004,793,507+1%+$720,000
D
2018-10-15
ALLOAllogene Therapeutics, Inc.Belldegrun ArieDir, 10%P - Purchase$18.00+35,0002,020,586+2%+$630,000
D
2018-10-15
ALLOAllogene Therapeutics, Inc.Tpg Group Holdings (Sbs) Advisors, Inc.10%P - Purchase$18.00+675,00023,135,061+3%+$12,150,000
DM
2018-10-15
RGNXRegenxbio Inc.Yoo StephenChief Medical OfficerS - Sale+OE$60.28-20,4140-100%-$1,230,541
2018-10-15
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale$59.37-7,500137,283-5%-$445,275
2018-10-15
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale$59.35-7,510326,000-2%-$445,745
D
2018-10-15
VCELVericel CorpMichel Gerard JCFO, VP, Corp. DevelopmentS - Sale+OE$12.65-15,000150,960-9%-$189,750
D
2018-10-15
SGMOSangamo Therapeutics, IncYi KathySVP, CFOS - Sale+OE$13.97-5,0007,250-41%-$69,850
2018-10-12
BCDABiocardia, Inc.McClung DavidCFOP - Purchase$2.64+5004,600+12%+$1,318
D
2018-10-10
BLUEBluebird Bio, Inc.Walsh Jeffrey T.Chief FinancialS - Sale+OE$135.23-1,50035,495-4%-$202,839
M
2018-10-10
ACORAcorda Therapeutics IncScopia Capital Management LP10%S - Sale$16.98-143,5766,542,153-2%-$2,437,305
2018-10-11
BCDABiocardia, Inc.Stertzer Simon HDirP - Purchase$2.70+1,0003,581,0940%+$2,700
D
2018-10-09
KODKodiak Sciences Inc.Baker Bros. Advisors LPDir, 10%P - Purchase$10.00+2,500,0008,374,935+43%+$25,000,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top